MARKET DEFINITION

Acoustic neuromas are non-cancerous (benign) brain tumors. Another name for it is vestibular schwannoma. A benign brain tumor is an abnormal development in the brain that typically develops slowly over a long period and does not spread to other body organs. Acoustic neuromas, which can cause problems like hearing loss and shakiness, originate in the nerve that controls hearing and balance. They occasionally become dangerous if they get very large, but for the most part, they are discovered and treated earlier on. Adults between the ages of 30 and 60 are typically affected by acoustic neuromas, which typically have no apparent origin. However, a tiny minority of instances are brought on by the genetic disorder neurofibromatosis type 2. (NF2).

MARKET DYNAMICS  

The acoustic neuroma market is predicted to rise in the coming years due to factors such as medicine cost-effectiveness, an increase in R&D efforts for product enhancement, and government initiatives for healthcare sector development. On the other hand, several new medications are being introduced by market participants, which is anticipated to present prospects for the acoustic neuroma market to expand. Opportunities for market growth are created by the rise in the number of acoustic neuroma therapeutics given through retail pharmacies and the rise in the number of retail pharmacies in developed nations. Additionally, because retail pharmacies are more convenient for customers to reach, patients prefer them for drug purchases.

REPORT SCOPE  

The report titled “Global Acoustic Neuroma Market – Size, Share, Growth, Opportunities, and Competitive Analysis, 2022 – 2028” offers strategic visions into the global Acoustic Neuroma market along with the market size (Value in “US$ Mn”) for the historical period 2017 to 2021 and estimates for the forecast period 2022 to 2028. The RI report is an in-depth study of the global Acoustic Neuroma market with a strong focus on key market trends, vital player strategies, and market forecasts. The study also covers key market dynamics, including drivers, restraints, opportunities, challenges, and existing and upcoming pathways that help CXOs make critical business decisions effectively. The global Acoustic Neuroma Market is predicted to grow at a significant CAGR over the forecast period from 2022 to 2028.

GEOGRAPHICAL OVERVIEW

The research report includes a detailed overview of the industry comprising quantitative and qualitative information. It gives a broad overview of the worldwide market forecasts for major segments. It also includes market size and forecast projections for five key regions: North America, Europe, Asia-Pacific (APAC), South America, and the Middle East & Africa (MEA), for the years 2017 to 2028. The market is further divided by categories and countries within each province. The research scrutinizes and forecasts over 20 nations worldwide, as well as the present trend and possibilities in these regions.

MARKET SEGMENTATION

The Global Acoustic Neuroma Market is segmented based on Treatment Type, End-User, and region. Based on Treatment Type, the market has been segmented into Medicines, Radiation Therapy and Surgery, whereas based on End-User, the market comprises Hospitals, Homecare, Specialty Clinics and Others

COMPETITION LANDSCAPE  

The RI research report discusses noteworthy developments in the industry as well as organic and inorganic growth strategies being adopted by the Acoustic Neuroma market players. The report covers industry activities, including new product launches, mergers & acquisitions, business partnerships, and various expansion initiatives being undertaken by the active players in the market. These developments pave the path for various market participants to strengthen their positioning as well as expand their consumer base. The positive market outlook for the global Acoustic Neuroma market is anticipated to present lucrative growth opportunities to the market players. The report also offers detailed profiles of major players in the global Acoustic Neuroma market, emphasizing the strategic initiatives, financial information, SWOT analysis, and key development in the Acoustic Neuroma industry in the past three years.

Key players in the Global Acoustic Neuroma Market have adopted various organic as well as inorganic growth strategies to strengthen their market positioning. Prominent players in the market include:

• PLx Pharma Inc
• Merck & Co., Inc.
• Novartis AG
• Pfizer Inc.
• Hoffmann-La Roche Ltd
• Amgen Inc
• Advanced Bionics AG
• Accuray Incorporated
• Teva Pharmaceuticals Industries Ltd
• Mylan N.V.
• General Electric
• Siemens Healthcare GmbH
• Koninklijke Philips N.V
• Shimadzu Corporation

COVID-19 IMPACT ANALYSIS ON GLOBAL ACOUSTIC NEUROMA MARKET  

The COVID-19 pandemic is still a very personal, individual experience that is also a once-in-a-lifetime worldwide phenomenon with far-reaching consequences. The epidemic has wreaked havoc on people's lives in all nations and communities and also had a negative impact on global economic development in 2020, unlike anything seen in almost a century. The pandemic severely impacted key economies such as India, Brazil, the U.S., France, Russia, the UK, Italy, Turkey, and Argentina. According to estimates, the virus slowed global economic growth by -3.4 percent to -7.6 percent in 2020, with a rebound of 4.2 percent to 5.6 percent expected in 2021. In 2020, global commerce was expected to decline by 5.3 percent, but it is expected to rise by 8.0 percent in 2021.

In contrast to the global economic downturn in the first half of 2020, the economy began to showcase symptoms of a two-track recovery post the second quarter of 2020, with a fledgling rebound in developed nations, however, slower growth in emerging economies. The outbreak of the Covid-19 pandemic has not only resulted in halted production activity but has also disrupted the global supply chain. The research goes on to evaluate the current and future implications of the COVID-19 pandemic both on the target as well as broader market, thereby, providing accurate and trustworthy forecasts.

RESEARCH PROGRAM DESIGN

KEY QUESTIONS ANSWERED  

1. What is the current size of the global Acoustic Neuroma market?
2. What will be the growth rate of the market over the forecast period?
3. Who are the key manufacturers/vendors in the Acoustic Neuroma market space?
4. What are the major market opportunities and market risks faced by the market?
5. What is the impact of COVID-19 on the market?
6. What are the revenue, sales, and price analysis of the top manufacturers in this market?
7. What are the key outcomes of Porter's five forces model?
8. Who are the distributors, traders, and vendors in the industry?

REASONS FOR BUYING THIS REPORT:  

• The report offers comprehensive data on the Acoustic Neuroma market elaborating on the current state and future growth prospects both globally and regionally
• It offers a six-year market forecast trend evaluating the impact of drivers and restraints and supporting factors for growth
• The report offers deep-dive insights into each market segment and critical factors responsible for its growth
• The report presents precise picture of the dynamic competitive landscape which helps our client advance their market position
• The comprehensive analysis of the market along with the inclusion of analyst recommendations ensures that our clients make informed business decisions
• Cross-segment country-level analysis included in the report which provides granular analysis of more than 20+ countries covered in the report scope
• The study includes detailed profiles of major manufacturers to help our readers gain holistic overview of the market competitors and consequently align their business strategies

Chapter 1. Executive Summary
1.1. Market Outlook
1.2. Market Segment Outlook
1.3. Geography Outlook
1.4. Absolute $ Opportunity
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Scope, Definition, and Assumptions
2.3. Data Sources
2.3.1. Secondary Sources
2.3.1.1. Preliminary Data Mining
2.3.2. Primary Sources
2.3.2.1. Statistical Model
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective
Chapter 3. Market Outlook
3.1. Introduction
3.2. Key Trends
3.2.1. Treatment Type Trends
3.2.2. End-User Trends
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Impact Analysis of Market Drivers
3.3.2. Market Restraints
3.3.2.1. Impact Analysis of Market Restraints
3.3.3. Market Opportunities
3.3.3.1. Impact Analysis of Market Opportunities
3.3.4. Market Challenges
3.3.4.1. Impact Analysis of Market Challenges
3.4. Porter’s Five Forces’ Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of New Entrant
3.4.4. Threat of Substitutes
3.4.5. Competitive Rivalry
3.5. Value Chain Analysis: Global Acoustic Neuroma Market
3.6. COVID-19 Impact Assessment in Acoustic Neuroma Market
3.6.1. Impact Assessment on Global Acoustic Neuroma Market
3.6.2. Market Trends and Opportunities in the Covid-19 Landscape
Chapter 4. Global Acoustic Neuroma Market Overview, By Treatment Type, 2017 - 2028 (USD Million)
4.1. Global Acoustic Neuroma Market Share, By Treatment Type, 2017 - 2028 (USD Million)
4.1.1. Medicines
4.1.2. Radiation Therapy
4.1.3. Surgery
Chapter 5. Global Acoustic Neuroma Market Overview, By End-User, 2017 - 2028 (USD Million)
5.1. Global Acoustic Neuroma Market Share, By End-User, 2017 - 2028 (USD Million)
5.1.1. Hospitals
5.1.2. Homecare
5.1.3. Specialty Clinics
5.1.4. Others
Chapter 6. Global Acoustic Neuroma Market Overview, By Geography, 2017 - 2028 (USD Million)
6.1. Global Acoustic Neuroma Market Share, By Geography, 2017 - 2028 (USD Million)
6.1.1. Market End-User and Projections, by Countries, 2017 - 2028 (USD Million)
6.1.2. Market Share and CAGR Comparison, by Countries, 2021 (%)
Chapter 7. North America Acoustic Neuroma Market Overview, By Countries, 2017 - 2028 (USD Million)
7.1. North America Acoustic Neuroma Market Overview, 2017 - 2028 (USD Million)
7.1.1. Market End-User and projections, 2017 - 2028 (USD Million)
7.1.2. North America Acoustic Neuroma Market Overview, By Treatment Type, 2017 - 2028 (USD Million)
7.1.3. North America Acoustic Neuroma Market Overview, By End-User, 2017 - 2028 (USD Million)
7.2. North America Acoustic Neuroma Market Overview, By Countries, 2017 - 2028 (USD Million)
7.2.1. U.S. Acoustic Neuroma Market Overview, 2017 - 2028 (USD Million)
7.2.1.1. U.S. Acoustic Neuroma Market Overview, By Treatment Type, 2017 - 2028 (USD Million)
7.2.1.2. U.S. Acoustic Neuroma Market Overview, By End-User, 2017 - 2028 (USD Million)
7.2.2. Canada Acoustic Neuroma Market Overview, 2017 - 2028 (USD Million)
7.2.2.1. Canada Acoustic Neuroma Market Overview, By Treatment Type, 2017 - 2028 (USD Million)
7.2.2.2. Canada Acoustic Neuroma Market Overview, By End-User, 2017 - 2028 (USD Million)
7.2.3. Mexico Acoustic Neuroma Market Overview, 2017 - 2028 (USD Million)
7.2.3.1. Mexico Acoustic Neuroma Market Overview, By Treatment Type, 2017 - 2028 (USD Million)
7.2.3.2. Mexico Acoustic Neuroma Market Overview, By End-User, 2017 - 2028 (USD Million)
Chapter 8. Europe Acoustic Neuroma Market Overview, By Countries, 2017 - 2028 (USD Million)
8.1. Europe Acoustic Neuroma Market Overview, 2017 - 2028 (USD Million)
8.1.1. Market End-User and projections, 2017 - 2028 (USD Million)
8.1.2. Europe Acoustic Neuroma Market Overview, By Treatment Type, 2017 - 2028 (USD Million)
8.1.3. Europe Acoustic Neuroma Market Overview, By End-User, 2017 - 2028 (USD Million)
8.2. Europe Acoustic Neuroma Market Overview, By Countries, 2017 - 2028 (USD Million)
8.2.1. Germany Acoustic Neuroma Market Overview, 2017 - 2028 (USD Million)
8.2.1.1. Germany Acoustic Neuroma Market Overview, By Treatment Type, 2017 - 2028 (USD Million)
8.2.1.2. Germany Acoustic Neuroma Market Overview, By End-User, 2017 - 2028 (USD Million)
8.2.2. France Acoustic Neuroma Market Overview, 2017 - 2028 (USD Million)
8.2.2.1. France Acoustic Neuroma Market Overview, By Treatment Type, 2017 - 2028 (USD Million)
8.2.2.2. France Acoustic Neuroma Market Overview, By End-User, 2017 - 2028 (USD Million)
8.2.3. UK Acoustic Neuroma Market Overview, 2017 - 2028 (USD Million)
8.2.3.1. UK Acoustic Neuroma Market Overview, By Treatment Type, 2017 - 2028 (USD Million)
8.2.3.2. UK Acoustic Neuroma Market Overview, By End-User, 2017 - 2028 (USD Million)
8.2.4. Italy Acoustic Neuroma Market Overview, 2017 - 2028 (USD Million)
8.2.4.1. Italy Acoustic Neuroma Market Overview, By Treatment Type, 2017 - 2028 (USD Million)
8.2.4.2. Italy Acoustic Neuroma Market Overview, By End-User, 2017 - 2028 (USD Million)
8.2.5. Spain Acoustic Neuroma Market Overview, 2017 - 2028 (USD Million)
8.2.5.1. Spain Acoustic Neuroma Market Overview, By Treatment Type, 2017 - 2028 (USD Million)
8.2.5.2. Spain Acoustic Neuroma Market Overview, By End-User, 2017 - 2028 (USD Million)
8.2.6. NORDIC Acoustic Neuroma Market Overview, 2017 - 2028 (USD Million)
8.2.6.1. NORDIC Acoustic Neuroma Market Overview, By Treatment Type, 2017 - 2028 (USD Million)
8.2.6.2. NORDIC Acoustic Neuroma Market Overview, By End-User, 2017 - 2028 (USD Million)
8.2.7. Russia and CIS Acoustic Neuroma Market Overview, 2017 - 2028 (USD Million)
8.2.7.1. Russia and CIS Acoustic Neuroma Market Overview, By Treatment Type, 2017 - 2028 (USD Million)
8.2.7.2. Russia and CIS Acoustic Neuroma Market Overview, By End-User, 2017 - 2028 (USD Million)
8.2.8. Rest of Europe Acoustic Neuroma Market Overview, 2017 - 2028 (USD Million)
8.2.8.1. Rest of Europe Acoustic Neuroma Market Overview, By Treatment Type, 2017 - 2028 (USD Million)
8.2.8.2. Rest of Europe Acoustic Neuroma Market Overview, By End-User, 2017 - 2028 (USD Million)
Chapter 9. Asia Pacific Acoustic Neuroma Market Overview, By Countries, 2017 - 2028 (USD Million)
9.1. Asia Pacific Acoustic Neuroma Market Overview, 2017 - 2028 (USD Million)
9.1.1. Market End-User and projections, 2017 - 2028 (USD Million)
9.1.2. Asia Pacific Acoustic Neuroma Market Overview, By Treatment Type, 2017 - 2028 (USD Million)
9.1.3. Asia Pacific Acoustic Neuroma Market Overview, By End-User, 2017 - 2028 (USD Million)
9.2. Asia Pacific Acoustic Neuroma Market Overview, By Countries, 2017 - 2028 (USD Million)
9.2.1. India Acoustic Neuroma Market Overview, 2017 - 2028 (USD Million)
9.2.1.1. India Acoustic Neuroma Market Overview, By Treatment Type, 2017 - 2028 (USD Million)
9.2.1.2. India Acoustic Neuroma Market Overview, By End-User, 2017 - 2028 (USD Million)
9.2.2. China Acoustic Neuroma Market Overview, 2017 - 2028 (USD Million)
9.2.2.1. China Acoustic Neuroma Market Overview, By Treatment Type, 2017 - 2028 (USD Million)
9.2.2.2. China Acoustic Neuroma Market Overview, By End-User, 2017 - 2028 (USD Million)
9.2.3. Japan Acoustic Neuroma Market Overview, 2017 - 2028 (USD Million)
9.2.3.1. Japan Acoustic Neuroma Market Overview, By Treatment Type, 2017 - 2028 (USD Million)
9.2.3.2. Japan Acoustic Neuroma Market Overview, By End-User, 2017 - 2028 (USD Million)
9.2.4. ASEAN Acoustic Neuroma Market Overview, 2017 - 2028 (USD Million)
9.2.4.1. ASEAN Acoustic Neuroma Market Overview, By Treatment Type, 2017 - 2028 (USD Million)
9.2.4.2. ASEAN Acoustic Neuroma Market Overview, By End-User, 2017 - 2028 (USD Million)
9.2.5. South Korea Acoustic Neuroma Market Overview, 2017 - 2028 (USD Million)
9.2.5.1. South Korea Acoustic Neuroma Market Overview, By Treatment Type, 2017 - 2028 (USD Million)
9.2.5.2. South Korea Acoustic Neuroma Market Overview, By End-User, 2017 - 2028 (USD Million)
9.2.6. Australia Acoustic Neuroma Market Overview, 2017 - 2028 (USD Million)
9.2.6.1. Australia Acoustic Neuroma Market Overview, By Treatment Type, 2017 - 2028 (USD Million)
9.2.6.2. Australia Acoustic Neuroma Market Overview, By End-User, 2017 - 2028 (USD Million)
9.2.7. Rest of Asia Pacific Acoustic Neuroma Market Overview, 2017 - 2028 (USD Million)
9.2.7.1. Rest of Asia Pacific Acoustic Neuroma Market Overview, By Treatment Type, 2017 - 2028 (USD Million)
9.2.7.2. Rest of Asia Pacific Acoustic Neuroma Market Overview, By End-User, 2017 - 2028 (USD Million)
Chapter 10. South America Acoustic Neuroma Market Overview, By Countries, 2017 - 2028 (USD Million)
10.1. South America Acoustic Neuroma Market Overview, 2017 - 2028 (USD Million)
10.1.1. Market End-User and projections, 2017 - 2028 (USD Million)
10.1.2. South America Acoustic Neuroma Market Overview, By Treatment Type, 2017 - 2028 (USD Million)
10.1.3. South America Acoustic Neuroma Market Overview, By End-User, 2017 - 2028 (USD Million)
10.2. South America Acoustic Neuroma Market Overview, By Countries, 2017 - 2028 (USD Million)
10.2.1. Brazil Acoustic Neuroma Market Overview, 2017 - 2028 (USD Million)
10.2.1.1. Brazil Acoustic Neuroma Market Overview, By Treatment Type, 2017 - 2028 (USD Million)
10.2.1.2. Brazil Acoustic Neuroma Market Overview, By End-User, 2017 - 2028 (USD Million)
10.2.2. Argentina Acoustic Neuroma Market Overview, 2017 - 2028 (USD Million)
10.2.2.1. Argentina Acoustic Neuroma Market Overview, By Treatment Type, 2017 - 2028 (USD Million)
10.2.2.2. Argentina Acoustic Neuroma Market Overview, By End-User, 2017 - 2028 (USD Million)
10.2.3. Rest of South America Acoustic Neuroma Market Overview, 2017 - 2028 (USD Million)
10.2.3.1. Rest of South America Acoustic Neuroma Market Overview, By Treatment Type, 2017 - 2028 (USD Million)
10.2.3.2. Rest of South America Acoustic Neuroma Market Overview, By End-User, 2017 - 2028 (USD Million)
Chapter 11. Middle East & Africa Acoustic Neuroma Market Overview, By Countries, 2017 - 2028 (USD Million)
11.1. Middle East & Africa Acoustic Neuroma Market Overview, 2017 - 2028 (USD Million)
11.1.1. Market End-User and projections, 2017 - 2028 (USD Million)
11.1.2. Middle East & Africa Acoustic Neuroma Market Overview, By Treatment Type, 2017 - 2028 (USD Million)
11.1.3. Middle East & Africa Acoustic Neuroma Market Overview, By End-User, 2017 - 2028 (USD Million)
11.2. Middle East & Africa Acoustic Neuroma Market Overview, By Countries, 2017 - 2028 (USD Million)
11.2.1. GCC Acoustic Neuroma Market Overview, 2017 - 2028 (USD Million)
11.2.1.1. GCC Acoustic Neuroma Market Overview, By Treatment Type, 2017 - 2028 (USD Million)
11.2.1.2. GCC Acoustic Neuroma Market Overview, By End-User, 2017 - 2028 (USD Million)
11.2.2. South Africa Acoustic Neuroma Market Overview, 2017 - 2028 (USD Million)
11.2.2.1. South Africa Acoustic Neuroma Market Overview, By Treatment Type, 2017 - 2028 (USD Million)
11.2.2.2. South Africa Acoustic Neuroma Market Overview, By End-User, 2017 - 2028 (USD Million)
11.2.3. Rest of Middle East & Africa Acoustic Neuroma Market Overview, 2017 - 2028 (USD Million)
11.2.3.1. Rest of Middle East & Africa Acoustic Neuroma Market Overview, By Treatment Type, 2017 - 2028 (USD Million)
11.2.3.2. Rest of Middle East & Africa Acoustic Neuroma Market Overview, By End-User, 2017 - 2028 (USD Million)
Chapter 12. Competitive Landscape
12.1. Competitive Environment, 2021
12.2. Strategic Framework
12.2.1. Partnership/Collaborations/Agreement
12.2.2. Expansion
12.2.3. Mergers & Acquisitions
12.2.4. New Product Development
Chapter 13. Key Vendor Analysis
13.1. PLx Pharma Inc
13.1.1. Business Overview
13.1.2. Product Benchmarking
13.1.3. Financial Data
13.1.4. Strategic Overview
13.1.5. Key Developments
13.1.6. SWOT Analysis
13.2. Merck & Co., Inc.
13.2.1. Business Overview
13.2.2. Product Benchmarking
13.2.3. Financial Data
13.2.4. Strategic Overview
13.2.5. Key Developments
13.2.6. SWOT Analysis
13.3. Novartis AG
13.3.1. Business Overview
13.3.2. Product Benchmarking
13.3.3. Financial Data
13.3.4. Strategic Overview
13.3.5. Key Developments
13.3.6. SWOT Analysis
13.4. Pfizer Inc.
13.4.1. Business Overview
13.4.2. Product Benchmarking
13.4.3. Financial Data
13.4.4. Strategic Overview
13.4.5. Key Developments
13.4.6. SWOT Analysis
13.5. F. Hoffmann-La Roche Ltd
13.5.1. Business Overview
13.5.2. Product Benchmarking
13.5.3. Financial Data
13.5.4. Strategic Overview
13.5.5. Key Developments
13.5.6. SWOT Analysis
13.6. Amgen Inc
13.6.1. Business Overview
13.6.2. Product Benchmarking
13.6.3. Financial Data
13.6.4. Strategic Overview
13.6.5. Key Developments
13.6.6. SWOT Analysis
13.7. Advanced Bionics AG
13.7.1. Business Overview
13.7.2. Product Benchmarking
13.7.3. Financial Data
13.7.4. Strategic Overview
13.7.5. Key Developments
13.7.6. SWOT Analysis
13.8. Accuray Incorporated
13.8.1. Business Overview
13.8.2. Product Benchmarking
13.8.3. Financial Data
13.8.4. Strategic Overview
13.8.5. Key Developments
13.8.6. SWOT Analysis
13.9. Teva Pharmaceuticals Industries Ltd
13.9.1. Business Overview
13.9.2. Product Benchmarking
13.9.3. Financial Data
13.9.4. Strategic Overview
13.9.5. Key Developments
13.9.6. SWOT Analysis
13.10. Mylan N.V.
13.10.1. Business Overview
13.10.2. Product Benchmarking
13.10.3. Financial Data
13.10.4. Strategic Overview
13.10.5. Key Developments
13.10.6. SWOT Analysis
13.11. General Electric
13.11.1. Business Overview
13.11.2. Product Benchmarking
13.11.3. Financial Data
13.11.4. Strategic Overview
13.11.5. Key Developments
13.11.6. SWOT Analysis
13.12. Siemens Healthcare GmbH
13.12.1. Business Overview
13.12.2. Product Benchmarking
13.12.3. Financial Data
13.12.4. Strategic Overview
13.12.5. Key Developments
13.12.6. SWOT Analysis
13.13. Koninklijke Philips N.V
13.13.1. Business Overview
13.13.2. Product Benchmarking
13.13.3. Financial Data
13.13.4. Strategic Overview
13.13.5. Key Developments
13.13.6. SWOT Analysis
13.14. Shimadzu Corporation
13.14.1. Business Overview
13.14.2. Product Benchmarking
13.14.3. Financial Data
13.14.4. Strategic Overview
13.14.5. Key Developments
13.14.6. SWOT Analysis
Chapter 14. Future Outlook of the Market